Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $2.41 | Prev. Close $2.38 | Circuit Range N/A |
Day Range $2.38 - $2.44 | Year Range $1.34 - $47.31 | Volume 819 |
Average Traded $2.41 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $2.41 | $2.44 | +0.00% |
12-Nov-25 | $2.41 | $2.44 | -2.79% |
11-Nov-25 | $2.42 | $2.51 | +2.87% |
10-Nov-25 | $2.36 | $2.44 | +6.09% |
07-Nov-25 | $2.24 | $2.30 | +0.00% |
06-Nov-25 | $2.38 | $2.30 | -5.35% |
05-Nov-25 | $2.35 | $2.43 | +2.10% |